Resources
Welcome to the Michigan Opioid Collaborative (MOC) resources page. Here you can access all of the many helpful toolkits, guides, webinar (videos shown at the bottom), and more that we have available. We earnestly hope you find everything you need to help you and your patients. Thank you for using our resources and helping to make healthcare a more inclusive and safer place for all patients!
How to Download Our Documents
The best way to use our resources is to download them:
- Simply click on the link/resource you wish to use below.
- Once the link opens you will see the “download” button at the top. The button may be to the top left or the top right and will either say download or have the download icon.
- Here is an example of the download icon
.
- Here is an example of the download icon
- Once you click on the download buttons, a save box will pop up.
- Inside of the save box, select a location/folder on your laptop or device to save the file, then select save.
- Some links will automatically open a save pop-up box once you click them. If this happens, follow step 4 above.
- After you have downloaded your file, you’re done!
- If your link opened in a browser or the cloud app and you want to return to the MOC page after downloading, click the back arrow at the top left of your internet browser.
MOC Resources
MOUD Treatment Implementation
Billing
Clinical Guides and Algorithms
Diversion Procedures
General OBAT Office Implementation Policies & Templates
- Clinical Pathway for Medication for Addiction Treatment | Boston Medical Center
- Coordination of Care Letter Example
- Epic Dotphrase Counseling Documentation | NIDA
- Gabapentin Statement of Understanding | MidMichigan Community Health Services
- MAT Business Plan | PCSS
- Medical Management Visit | SAMHSA
- Practical Tools for Prescribing Buprenorphine in Primary Care | SAMHSA
- Title 42 of the Code of Federal Regulations Part 2: Confidentiality of Substance Use Disorder Patient Records | SAMHSA
Induction or Initiation
First Appointment and Intake Resources
Manuals and Guidelines
- Medications for Opioid Use Disorder Manual | SAMHSA
- National Practice Guideline for the Treatment of Opioid Use Disorder | ASAM
- OBAT Policy and Procedure Manual | Boston Medical Center
- Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care | PCSS
- Trauma-Informed Care in Behavioral Health Services | SAMHSA
Patient Resources
Perioperative Buprenorphine Management
Pregnant and Perinatal Patients
Screening and Assessment Tools
Sample Treatment Agreement
Urine Drug Screen Information
MOC Toolkits
- Alcohol Use Disorder Toolkit
- Cannabis Use Disorder Toolkit
- Destigmatizing Language Guide
- Harm Reduction Principles
- Kratom Toolkit
- GREAT MOMs Toolkit
- Polysubstance: Opioid and Stimulant Use Toolkit
- Stimulant Use Disorder Toolkit
- Telecounseling Intervention Manual Short Version
- Telecounseling Intervention Manual Long Version
- Top 10 Ideas to Take it to the Next Level
- Top 10 Quick and Easy Ways to Enhance Access to MOUD Care
MOC Webinars
View All MOC Webinars on our YouTube Channel
DISCLAIMER: These webinars are pre-recorded and are NOT included with the free on-demand training. This means that they are no longer eligible for any kind of continuing education credits. If you watch any of these webinars and see a QR code at the end, it will not work.
2023
- A Modern Understanding of the Addicted Brain
- Alcohol Use Disorder – Epidemiology and Clinical Best Practices
- An Introduction to Treating Patients with Buprenorphine
- Buprenorphine for Pain in the Setting of Terminal Disease
- Enhancing Access to Medications for Opioid Use Disorder
- Introduction to Treating Patients with Buprenorphine for Residents and New Prescribers
- Kratom – Aggression and Psychosis
- Michigan’s Substance Use Vulnerability Index (MOC/MDHHS)
- Motivational Interviewing Lunch-N-Learn Affirmations
- Novel Psychoactive Substances of 2023
- Perinatal Mini Series: Part 1 – Trauma-Informed Care for Perinatal Patients (MOC/MC3)
- Perinatal Mini Series: Part 2 – MOUD in Perinatal Care (MOC/MC3)
- Perinatal Mini Series: Part 3 – Psychiatric Care and Perinatal Patients (MOC/MC3)
- Perinatal Mini Series: Part 4 – Postpartum Continuation & Transitions of Care (MOC/MC3)
- Post X Waiver – Improving Buprenorphine Access at the Community Pharmacy
- Prescription PrEP Part II – PrEP is EZ
- Stigma and Substance Use Disorders
- Sublocade 101
- Substance Use During Adolescence – An Overview of Trends, Risk Factors, and Consequences
- SUD/MOUD in our Communities: Break the Stigma to Break the Cycle
- Telehealth for Substance Use Disorder in a Post-Pandemic World
- The Intersection between Human Trafficking and Drug Trafficking
- Xylazine What we Know, What we Don’t, and What we Can do Now
2022
- Expanding Access to MOUD Through Medication First – Low Barrier Models of Care
- Non-Medical Use of Prescription Stimulants – Tools for Identification & Prevention
- Trauma and Substance Use Disorder – Delivering Trauma Informed Care
- Treating Opioid Use Disorder in Pregnancy (MOC/GREAT MOMs)
2021
- Buprenorphine for Chronic Pain – A Way Out of the Hole
- Motivational Interviewing: Affirmations
- Motivational Interviewing Spirit: Building, Growing, & Repairing Connection with Clients
- Mood and Anxiety Disorders in Pregnancy and Postpartum
- Psychostimulants: Cocaine, Amphetamine, and Methamphetamine (MOC/UMATS)
- Sex and Drugs – Integrating Reproductive and Sexual Health Services in OUD Treatment
- Tobacco Use Disorder
2020/2019
- Benzodiazepines with Dr. Christopher Blazes, MD (2019)
- Drug Screening – Practical Tips for Clinicians (2020)
- Substance Use Disorder in Rural Communities (2020)
Hepatitis C Education
Epidemiology and Screening (2021)
- Hepatitis C Virus – Part 1: Epidemiology and Screening Webinar – YouTube
- Hepatitis C Epidemiology and Screening Free On-Demand Webinar w/ 0.5 CME Credit
- Hepatitis C Epidemiology and Screening Webinar Slides
Treatment (2021)
- Hepatitis C Virus – Part 2: HCV Treatment Webinar – YouTube
- Hepatitis C Treatment Free On-Demand Webinar w/ 1 CME Credit
- Hepatitis C Treatment Webinar Slides
Post Treatment (2021)
Licensing/Regulatory
DEA Second Temporary Extension of COVID-19 Telemedicine
Flexibilities for Prescription of Controlled Medications
The DEA has issued a second temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Existing DEA regulations for new and established practitioner-patient relationships have been extended through 12/31/24.
DEA Training Requirements
Prescribers who are either renewing or applying for a new controlled substance DEA registration are required to complete 8-hours of SUD training due to the Medication Access and Training Expansion (MATE) Act.
Michigan Opioid Collaborative’s previous and upcoming free trainings and webinars will meet the new DEA SUD training requirements. Check out our events page for our upcoming events and look for the ones that say “Meets DEA SUD Training Requirements” or “DEA Training”.
SUD Service MAT License (Michigan Only) No Longer Required for Prescribing Buprenorphine
Per LARA (Department of Licensing and Regulatory Affairs), sites with more than 100 patients prescribed buprenorphine and/or naltrexone are no longer required to obtain a Substance Use Disorder Service MAT license!
X-License Requirement Removed
Pain Treatment
Hepatitis C
Education Resources and Guidelines
State and Federal Reports and Communications
Hepatitis C Webinars
Epidemiology and Screening (2021)
- Hepatitis C Virus – Part 1: Epidemiology and Screening Webinar – YouTube
- Hepatitis C Epidemiology and Screening Free On-Demand Webinar w/ 0.5 CME Credit
- Hepatitis C Epidemiology and Screening Webinar Slides
Treatment (2021)
- Hepatitis C Virus – Part 2: HCV Treatment Webinar – YouTube
- Hepatitis C Treatment Free On-Demand Webinar w/ 1 CME Credit
- Hepatitis C Treatment Webinar Slides
Post Treatment (2021)
Research Articles
Diversion
- A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
- Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience
- The relationship between diversion-related attitudes and sharing and selling buprenorphine
Emergency Department
- Cost Effectiveness of Emergency Department-Initiated Treatment for Opioid Dependence
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
- Emergency department-based peer support for opioid use disorder: Emergent functions and forms
- Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
- Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
- One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose
Finance
Hospital
Length of Treatment
MOUD Effectiveness
- Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
- Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
Polysubstance
Pregnancy
- Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
- Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
- Simultaneous quantification of buprenorphine, naloxone and phase Iand II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry
Primary Care
- Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
- A buprenorphine education and training program for primary care residents: Implementation and evaluation
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers
Stigma
- Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms
- Does Our Choice of Substance-Related Terms Influence Perceptions of Treatment Need? An Empirical Investigation with Two Commonly Used Terms
- Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
- Caring for Ms. L. — Overcoming My Fear of Treating Opioid Use Disorder
- Stigma as a fundamental hindrance to the United States opioid overdose crisis response
- Next Stage in Buprenorphine Treatment(Addresses misconceptions about MOUD)
- Interpreting Urine Drug Screen (UDS)
Other Substance Use Resources and Websites
Other substance use disorder treatment organizations and resources
- American Society of Addiction Medicine (ASAM)
- Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT)
- Provider Clinical Support System (PCSS)
- American Association for the Treatment of Opioid Dependence, Inc. (AATOD)
- Harm Reduction Approach to Treatment of All Substance Use Disorders
- National Harm Reduction Coalition
- County CMH Contact Information
Naloxone Education
Free On-Demand Training for MATE Act Education
Prescribers who are either renewing or applying for a new controlled substance DEA registration are required to complete 8-hours of SUD training due to the Medication Access and Training Expansion (MATE) Act. The requirement took effect on June 27th, 2023.
MOC has partnered with MyMichigan to offer free and convenient opportunities for prescribers to meet the new DEA requirements. If you are unable to attend our live webinars, you can access archived webinars at the MyMichigan website and still receive CME credit.
Stigma & Substance Use Disorders
Recorded on Feb. 20, 2023
1 CME Credit & 1 Credit for DEA Training
A Modern Understanding of the Addicted Brain
Recorded on April 17, 2023
1 CME Credit & 1 Credit for DEA Training
An Introduction to Treating Patients with Buprenorphine
Recorded on July 10, 2023
4 CME Credits & 4 Credits for DEA Training
Michigan’s Substance Use Vulnerability Index – Part I
Recorded on July 18, 2023
1 CME Credit & 1 Credit for DEA Training
Substance Use and Co-Occurring Psychiatric Disorders
Recorded on Sept. 23, 2022
1 CME Credit & 1 Credit for DEA Training
Enhancing Access to Medications for Opioid Use Disorder
Recorded on March 29, 2023
1 CME Credit & 1 Credit for DEA Training
Telehealth for Substance Use Disorder Treatment in a Post-Pandemic World
Recorded on May 8, 2023
1 CME Credit & 1 Credit for DEA Training
Substance Use During Adolescence: An overview of Trends
Recorded on July 14, 2023
1 CME Credit & 1 Credit for DEA Training
GREAT MOMs: Treating Opioid Use Disorder in Pregnancy
Recorded on Aug. 1, 2022
1 CME Credit & 1 Credit for DEA Training
MOC Webinars
DISCLAIMER: These webinars are pre-recorded and are NOT included with the free on-demand training. This means that they are not eligible for any kind of continuing education credits. If you watch any of these webinars and see a QR code at the end, it will not work.